PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Illumina stock at 6.08%, Natera at 5.97%, Biogen at 5.60%, Gilead Sciences at 5.23%, and Royalty Pharma at 5.15%.

Total Holdings

Top 10 Percentage

49.03%

Asset Class

Equity

ETF Category

Health

Assets

429.04M

PE Ratio

26.34

Breakdown by Country

Top 25 Holdings

Updated Oct 27, 2026

No.	Symbol	Name	Weight% Weight	Shares	Stock Price	% Change
1	ILMN	Illumina, Inc.	6.08%	95,399	288.79	3.33%
2	NTRA	Natera, Inc.	5.97%	63,745	424.27	3.27%
3	BIIB	Biogen Inc.	5.60%	97,222	244.05	-3.43%
4	GILD	Gilead Sciences, Inc.	5.23%	144,274	159.20	0.08%
5	RPRX	Royalty Pharma plc	5.15%	345,798	64.82	-0.70%
6	AMGN	Amgen Inc.	4.96%	48,534	451.83	0.87%
7	REGN	Regeneron Pharmaceuticals, Inc.	4.79%	25,749	813.27	-0.35%
8	VRTX	Vertex Pharmaceuticals Incorporated	4.61%	38,824	529.69	1.66%
9	MRNA	Moderna, Inc.	3.50%	73,715	214.17	2.98%
10	HALO	Halozyme Therapeutics, Inc.	3.14%	107,094	130.03	1.19%
11	EXEL	Exelixis, Inc.	3.08%	206,407	66.28	1.42%
12	QGEN	Qiagen N.V.	3.07%	268,212	50.33	0.32%
13	VCYT	Veracyte, Inc.	3.05%	265,837	50.31	0.06%
14	UTHR	United Therapeutics Corporation	3.04%	22,579	586.48	-0.80%
15	NVAX	Novavax, Inc.	2.83%	1,240,199	10.32	2.99%
16	TGTX	TG Therapeutics, Inc.	2.72%	211,250	57.40	1.70%
17	LEGN	Legend Biotech Corporation	2.70%	549,646	22.53	4.50%
18	VCEL	Vericel Corporation	2.67%	270,881	41.09	-5.04%
19	SRPT	Sarepta Therapeutics, Inc.	2.67%	618,787	19.32	2.28%
20	RGEN	Repligen Corporation	2.58%	64,437	184.69	5.06%
21	NBIX	Neurocrine Biosciences, Inc.	2.54%	76,336	145.53	-0.32%
22	PTGX	Protagonist Therapeutics, Inc.	2.50%	77,744	142.14	0.72%
23	INCY	Incyte Corporation	2.40%	90,252	116.87	0.23%
24	ANAB	AnaptysBio, Inc.	2.27%	200,573	50.50	1.75%
25	PTCT	PTC Therapeutics, Inc.	2.26%	159,351	63.02	1.50%

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now